Compass therapeutics to present at upcoming investment conferences

Boston, nov. 08, 2022 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced it will be presenting at the following investor conferences during the month of november 2022.

CMPX Ratings Summary

CMPX Quant Ranking